ArticleMolecules (Basel, Switzerland)2026
New Concepts for the Cascading Use of Biomass in Existing Value Chains in Central Europe.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Bioeconomy is an important concept of economic development, supported at the highest political levels. However, its successful implementation calls for action within local markets. This study, therefore, examined the market readiness to engage in bioeconomy growth and emerging value chains in Italy, Slovenia, Germany, Poland, Slovakia, and Austria. The objectives were to assess the market readiness for placing novel bioproducts based on by-products and waste from primary production and agri-food processing sectors, and to evaluate the economics of their production. Specific goals were to estimate the availability of by-products and waste used for making new products, evaluate the main directions and trends in the use of by-products and waste, analyse the main barriers and restrictions to by-product and waste supplies to new enterprises and innovative applications, and make an economic assessment of the market entry of innovative products and their development. The study showed that the oil industry, with a high residue potential, was most often chosen to market new products. Other sectors where value chains can be created or modified are the fruit, winery, grain and milling, wood, hemp, and vegetable industries. PESTEL analysis demonstrated that economic factors, at both national and global levels, are the most common barriers to supplying by-products and waste to new business entities. Technological factors also significantly impede the delivery of by-products and waste to such new enterprises and their processing into novel products. In contrast, social conditions are the main factors stimulating supply of by-products and waste to such new plants. The results provide a preliminary insight into the Central European market and its enormous development potential, which is already implicated in the context of growing bioeconomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.